HapMap, pharmacogenomics, and the goal of personalized prescribingO'SHAUGHNESSY, Kevin M.British journal of clinical pharmacology. 2006, Vol 61, Num 6, pp 783-786, issn 0306-5251, 4 p.Article

Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie aheadNEBERT, Daniel W; VESELL, Elliot S.European journal of pharmacology. 2004, Vol 500, Num 1-3, pp 267-280, issn 0014-2999, 14 p.Article

Stakeholder Views on Pharmacogenomic Testing : INDIVIDUALIZED PHARMACOTHERAPYPATEL, Haridarshan N; URSAN, Iulia D; ZUEGER, Patrick M et al.Pharmacotherapy. 2014, Vol 34, Num 2, pp 151-165, issn 0277-0008, 15 p.Article

A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3CAILLIER, Bertrand; LBPINE, Johanie; TOJCIC, Jelena et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 7, pp 481-495, issn 1744-6872, 15 p.Article

BeadArray-based solutions for enabling the promise of pharmacogenomics : Applying technologies towards safe and effective medicinesFAN, Jian-Bing; HU, Sean X; CRAUMER, William C et al.BioTechniques. 2005, Vol 39, Num 4, pp 583-588, issn 0736-6205, 6 p.Article

Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacyBURCZYNSKI, M. E.Toxicology letters. 2009, Vol 186, Num 1, pp 18-21, issn 0378-4274, 4 p.Article

Pharmacogenomics and drug responseMÜLLER, M.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 231-240, issn 0946-1965, 10 p.Article

Selecting SNPs for pharmacogenomic association studyTAE JIN AHN; PARK, Kyunghee; PARK, Taesung et al.International journal of data mining and bioinformatics (Print). 2012, Vol 6, Num 5, pp 521-534, issn 1748-5673, 14 p.Article

PharmGKB summary: very important pharmacogene information for CYP3A5LAMBA, Jatinder; HEBERT, Joan M; SCHUETZ, Erin G et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 7, pp 555-558, issn 1744-6872, 4 p.Article

Assessment of Pharmacologic Area Under the Curve When Baselines are VariableSCHEFF, Jeremy D; ALMON, Richard R; DUBOIS, Debra C et al.Pharmaceutical research. 2011, Vol 28, Num 5, pp 1081-1089, issn 0724-8741, 9 p.Article

Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic doseLEIRI, Ichiro; NISHIMURA, Chisa; YOSHIDA, Kenji et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 8, pp 495-505, issn 1744-6872, 11 p.Article

Pharmacogenomics : from bedside to clinical practiceMARSH, Sharon; MCLEOD, Howard L.Human molecular genetics (Print). 2006, Vol 15, issn 0964-6906, R89-R93, NSArticle

Emerging Roles for Pharmacists in Clinical Implementation of PharmacogenomicsOWUSU-OBENG, Aniwaa; WEITZEL, Kristin W; HATTON, Randy C et al.Pharmacotherapy. 2014, Vol 34, Num 10, pp 1102-1112, issn 0277-0008, 11 p.Article

Watson and crick 50 years on. From double helix to pharmacogenomicsSWEENEY, B. P.Anaesthesia. 2004, Vol 59, Num 2, pp 150-165, issn 0003-2409, 16 p.Article

An omics view of drug developmentALTMAN, Russ B; RUBIN, Daniel L; KLEIN, Teri E et al.Drug development research. 2004, Vol 62, Num 2, pp 81-85, issn 0272-4391, 5 p.Article

β₁-Adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapyTERRA, Steven G; HAMILTON, Karen K; YARANDI, Hossein N et al.Pharmacogenetics (London). 2005, Vol 15, Num 4, pp 227-234, issn 0960-314X, 8 p.Article

Β₁-Adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapyTERRA, Steven G; HAMILTON, Karen K; YARANDI, Hossein N et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 4, pp 227-234, issn 1744-6872, 8 p.Article

Pharmacogenomics of antiretroviral therapyHAAS, David W.Drug development research. 2004, Vol 62, Num 3, pp 213-220, issn 0272-4391, 8 p.Article

Pharmacogenomics in clinical practice and drug developmentHARPER, Andrew R; TOPOL, Eric J.Nature biotechnology (Print). 2012, Vol 30, Num 11, pp 1117-1124, issn 1087-0156, 8 p.Article

PharmacogenomicsMARSH, S.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix24-ix28, SUP9Conference Paper

Pharmacogenomics in clinical trialsLAGERCRANTZ, Jacob.Recent research developments in biophysics and biochemistry vol. 4 - 2004 Part I. Recent research developments in biophysics and biochemistry. 2004, pp 145-173, isbn 81-7736-214-3, 29 p.Book Chapter

Pharmacogenomics and the Future of Toxicology TestingPAL AGRAWAL, Yash; RENNERT, Hanna.Clinics in laboratory medicine. 2012, Vol 32, Num 3, issn 0272-2712, viii, 509-523 [16 p.]Article

A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland ChinaYUYU XIONG; MING WANG; KE FANG et al.Genomics (San Diego, Calif.). 2011, Vol 97, Num 5, pp 277-281, issn 0888-7543, 5 p.Article

Functional genomics approaches to studies of the cytochrome p450 superfamilyREZEN, Tadeja; CONTRERAS, Juan A; ROZMAN, Damjana et al.Drug metabolism reviews (Softcover ed.). 2007, Vol 39, Num 2-3, pp 389-399, issn 0360-2532, 11 p.Article

Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseasesPETROVSKI, Slavé; SZOEKE, Cassandra E; SHEFFIELD, Leslie J et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 2, pp 147-152, issn 1744-6872, 6 p.Article